Alpha 2.0
Login Register
» Articles » PMID: 35301548

The TARGET Trial As a Plea for Model-informed Precision Dosing of Piperacillin/tazobactam in Patients with Sepsis

Overview
Journal Intensive Care Med
Specialty Critical Care
Date 2022 Mar 18
PMID 35301548
Authors
Matthias Gijsen
Erwin Dreesen
Joost Wauters
Yves Debaveye
Isabel Spriet
Affiliations
Soon will be listed here.
Citing Articles

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.

Greppmair S, Brinkmann A, Roehr A, Frey O, Hagel S, Dorn C Intensive Care Med. 2023; 49(8):966-976.

PMID: 37439872 PMC: 10425489. DOI: 10.1007/s00134-023-07154-0.

Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review.

Haseeb A, Faidah H, Alghamdi S, Alotaibi A, Elrggal M, Mahrous A Front Pharmacol. 2022; 13:964005.

PMID: 36210807 PMC: 9532942. DOI: 10.3389/fphar.2022.964005.